These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6110656)

  • 41. Cholinergic syndrome following anticholinergic withdrawal in a schizophrenic patient abusing marijuana.
    Tandon R; Dutchak D; Greden JF
    Br J Psychiatry; 1989 May; 154():712-4. PubMed ID: 2597866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute extrapyramidal syndrome and neuroleptical malignant syndrome. A case report].
    Cesario V
    Recenti Prog Med; 2008 Mar; 99(3):146-8. PubMed ID: 18488526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.
    Thomas A; Onofrj M
    Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099
    [No Abstract]   [Full Text] [Related]  

  • 44. Parkinsonism following neuroleptic withdrawal.
    Nelli AC; Yarden PE; Guazzelli M; Feinberg I
    Arch Gen Psychiatry; 1989 Apr; 46(4):383-4. PubMed ID: 2564765
    [No Abstract]   [Full Text] [Related]  

  • 45. Neuroleptic malignant syndrome: an experience of four cases.
    Desai ND; Mundra VK; Gore YS; Diwan PJ; Jaydeokar SS; Jain V; Sutharsan R; Agarwal A; Moulick ND; Manocha SM
    J Assoc Physicians India; 1998 Jul; 46(7):653-4. PubMed ID: 12152854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tardive Tourette syndrome in an autistic patient after long-term neuroleptic administration.
    Stahl SM
    Am J Psychiatry; 1980 Oct; 137(10):1267-9. PubMed ID: 6106393
    [No Abstract]   [Full Text] [Related]  

  • 47. Cholinergic syndrome from psychotropic withdrawal in a marijuana abuser.
    Dilsaver SC; Leckrone J; Greden JF
    Psychosomatics; 1984 Aug; 25(8):632-4. PubMed ID: 6332335
    [No Abstract]   [Full Text] [Related]  

  • 48. Life-threatening neuroleptic withdrawal emergent syndrome resembling status dystonicus.
    Pugin D; Bally J; Horvath J; Pollak P; Gasche Y; Burkhard PR
    Parkinsonism Relat Disord; 2017 Feb; 35():96-97. PubMed ID: 27914829
    [No Abstract]   [Full Text] [Related]  

  • 49. Adverse reactions to sudden stoppage of drugs.
    Wahi S; Wahi PL
    J Assoc Physicians India; 1986 Mar; 34(3):205-6. PubMed ID: 2874126
    [No Abstract]   [Full Text] [Related]  

  • 50. Withdrawal phenomena associated with antidepressant and antipsychotic agents.
    Dilsaver SC
    Drug Saf; 1994 Feb; 10(2):103-14. PubMed ID: 7912078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concurrent haloperidol withdrawal and benztropine overdose: a case report.
    West RR; Newgreen DB
    Compr Psychiatry; 1978; 19(6):557-60. PubMed ID: 720041
    [No Abstract]   [Full Text] [Related]  

  • 52. Sedation effects on responsiveness: evaluating the reduction of antipsychotic medication in people with intellectual disability using a conditional probability approach.
    Smith C; Felce D; Ahmed Z; Fraser WI; Kerr M; Kiernan C; Emerson E; Robertson J; Allen D; Baxter H; Thomas J
    J Intellect Disabil Res; 2002 Sep; 46(Pt 6):464-71. PubMed ID: 12354317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phobic behavior after haloperidol withdrawal.
    Mizes JS
    Am J Psychiatry; 1984 Apr; 141(4):612. PubMed ID: 6703151
    [No Abstract]   [Full Text] [Related]  

  • 54. Persistent supersensitivity vomiting following neuroleptic withdrawal in an adolescent.
    Grob CS
    Biol Psychiatry; 1986 Apr; 21(4):398-401. PubMed ID: 3955115
    [No Abstract]   [Full Text] [Related]  

  • 55. Decrease in core temperature as an indication of cholinergic overdrive during amitriptyline withdrawal.
    Dilsaver SC; Majchrzak MJ
    Biol Psychiatry; 1987 Dec; 22(12):1485-7. PubMed ID: 3676377
    [No Abstract]   [Full Text] [Related]  

  • 56. [Acute anticholinergic syndrome following intentional ingestion of tropane alkaloids].
    Eugster C; Reutter FW
    Schweiz Rundsch Med Prax; 1987 May; 76(22):628-31. PubMed ID: 3616315
    [No Abstract]   [Full Text] [Related]  

  • 57. Maintenance antipsychotic trials and the effect of withdrawal.
    Munkholm K; Horowitz MA; Moncrieff J
    Lancet; 2022 Sep; 400(10357):995. PubMed ID: 36154688
    [No Abstract]   [Full Text] [Related]  

  • 58. Rebound thrombosis after stopping anticoagulants.
    Br Med J; 1966 Dec; 2(5526):1343-4. PubMed ID: 5957414
    [No Abstract]   [Full Text] [Related]  

  • 59. Cholinergic rebound following trazodone withdrawal?
    Montalbetti DJ; Zis AP
    J Clin Psychopharmacol; 1988 Feb; 8(1):73. PubMed ID: 3351007
    [No Abstract]   [Full Text] [Related]  

  • 60. Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?
    Blackman G; Oloyede E; Horowitz M; Harland R; Taylor D; MacCabe J; McGuire P
    Schizophr Bull; 2022 Jan; 48(1):176-189. PubMed ID: 34651184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.